Please login to the form below

Not currently logged in
Email:
Password:

olipudase alfa

This page shows the latest olipudase alfa news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s rare disease drug olipudase alfa scores in late-stage study

Sanofi’s rare disease drug olipudase alfa scores in late-stage study

Olipudase alfa is designed to replace the enzyme that is deficient in the inherited disease, also known as Neimann-Pick disease. ... Both of these findings are consistent across the clinical studies with olipudase alfa.

Latest news

  • Sanofi rare disease drug a breakthrough, says FDA Sanofi rare disease drug a breakthrough, says FDA

    The FDA gave the coveted status to olipudase alfa, which is designed to replace the enzyme that is deficient in the inherited disease, also known as acid sphingomyelinase deficiency (ASMD). ... Genzyme is developing olipudase alfa (GZ402665) for the type

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics